About
Opus Genetics, Inc. (NASDAQ:IRD) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 27 2026
Opus Genetics to Participate in Leading Medical Conferences in May 2026
Apr 10 2026
Opus Genetics Announces Data Presentations at the 2026 American Society of Cataract and Refractive Surgery Annual Meeting
Apr 6 2026
Opus Genetics Solidifies Leadership Position in Gene Therapy Development for Inherited Retinal Diseases with Strategic Long-Term Financing by Oberland Capital
Mar 24 2026
Opus Genetics Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2026
Mar 10 2026
Opus Genetics Announces Financial Results for Full Year 2025 and Provides Corporate Update
Financials
Revenue
$14.2 M
Market Cap
$323.73 M
EPS
-0.80